Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Gynecology

Free Subscription Articles published in Gynecol Endocrinol Retrieve available abstracts of 174 articles: HTML format

Single Articles

December 2026
1. SIMSEK E, Durdag GD, Yaginc DA, Yetkinel S, et al
   Comparison of uterine peristalsis in artificial hormone treatment versus aromatase inhibitor-stimulated frozen embryo transfer cycles.
   Gynecol Endocrinol. 2026;42:2602969.
   PubMed     Abstract available
   
   
   
2. LI L, You W, Zhang M
   Involvement of USP33 in ferritinophagy and ferroptosis in endometriosis through the Hippo-YAP pathway.
   Gynecol Endocrinol. 2026;42:2589605.
   PubMed     Abstract available
   
   
   
3. CAVALCANTI GS, Carvalho KC, Monteleone PAA, Chedraui P, et al
   Melatonin modulates granulosa cell angiogenesis differently in female- and male-factor infertility.
   Gynecol Endocrinol. 2026;42:2606440.
   PubMed     Abstract available
   
   
   
4. CHEN YF, Wang LH
   Neutrophil/albumin ratio positively associates with type 2 diabetes mellitus risk in women with prior gestational diabetes mellitus: moderation by body mass index.
   Gynecol Endocrinol. 2026;42:2607806.
   PubMed     Abstract available
   
   
   
5. PAN Y, Zhang Y, Teng X, Zhang Y, et al
   Role of NAT10-mediated RNA acetylation in premature ovarian insufficiency: a mechanistic review.
   Gynecol Endocrinol. 2026;42:2610551.
   PubMed     Abstract available
   
   
   
6. ZHAO W, Zhang Y, Ma H, Sun P, et al
   Characterization of the follicular fluid microbiome in endometriosis patients undergoing in vitro fertilization.
   Gynecol Endocrinol. 2026;42:2612148.
   PubMed     Abstract available
   
   
   
7. CHI H, Pan J, Yang Z, Huang H, et al
   Endometrial receptivity in polycystic ovary syndrome: altered biomarkers and underlying mechanisms.
   Gynecol Endocrinol. 2026;42:2610550.
   PubMed     Abstract available
   
   
   
8. ZHU X, Deng X, Li L, Zhao X, et al
   Intrauterine platelet-rich plasma infusion with hormone replacement therapy improves menstrual and pregnancy outcomes in thin endometrium patients undergoing frozen-thawed embryo transfer.
   Gynecol Endocrinol. 2026;42:2610084.
   PubMed     Abstract available
   
   
   
9. WEI X, Huang L, Li X
   Dydrogesterone versus levonorgestrel-releasing intrauterine system for abnormal uterine bleeding: a propensity score-matched analysis of long-term efficacy and recurrence.
   Gynecol Endocrinol. 2026;42:2612154.
   PubMed     Abstract available
   
   
   
10. 
    Statement of retraction: Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome.
    Gynecol Endocrinol. 2026;42:2625568.
    PubMed    
    
    
    December 2025
11. 
    Statement of retraction: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial.
    Gynecol Endocrinol. 2025;41:2554449.
    PubMed    
    
    
    
12. CHEN W, Xu D, Shao X, Song Q, et al
    Meta-analysis of the effects of semaglutide on body mass index (BMI) and blood lipid levels in polycystic ovary syndrome patients.
    Gynecol Endocrinol. 2025;41:2553052.
    PubMed     Abstract available
    
    
    
13. BARBAGALLO F, Cavallaro A, Cannarella R, Crafa A, et al
    A preliminary analysis of the relationship between follicle-stimulating hormone and metabolic parameters in postmenopausal women.
    Gynecol Endocrinol. 2025;41:2562195.
    PubMed     Abstract available
    
    
    
14. LIU L, Kang H, Li X, Yao H, et al
    Association between VDR Apa I polymorphism and subclinical hypothyroidism in patients with polycystic ovary syndrome: a pilot study.
    Gynecol Endocrinol. 2025;41:2566341.
    PubMed     Abstract available
    
    
    
15. MONLLOR-TORMOS A, Garcia-Perez MA, Tarin JJ, Garcia-Vigara A, et al
    Genetic variants of the androgen receptor and frailty in postmenopausal women.
    Gynecol Endocrinol. 2025;41:2565238.
    PubMed     Abstract available
    
    
    
16. HAN W, Song Y, Xu Y, Zhou F, et al
    Association analysis of MTHFR (C677T, A1298C) and MTRR (A66G) gene polymorphisms on susceptibility to gestational diabetes mellitus in Chinese pregnant women.
    Gynecol Endocrinol. 2025;41:2565256.
    PubMed     Abstract available
    
    
    
17. DOUXFILS J, Morimont L, Flerin N, Gaspard U, et al
    Evaluation of the safety profile of prolonged-release EE/DNG oral contraceptives: a critical appraisal.
    Gynecol Endocrinol. 2025;41:2571648.
    PubMed     Abstract available
    
    
    
18. WANG Z, You Y, Jun L, Long X, et al
    Factors influencing the occurrence of pre-eclampsia and the establishment of a risk prediction model: a retrospective study.
    Gynecol Endocrinol. 2025;41:2574870.
    PubMed     Abstract available
    
    
    
19. ARSHAD A, Armeni E, Broughton S, Ali A, et al
    Polycystic ovary syndrome: pragmatic management across levels of care.
    Gynecol Endocrinol. 2025;41:2574874.
    PubMed     Abstract available
    
    
    
20. PAN M, Qian Y, Jiang L, Cao C, et al
    Glucose-dependent insulinotropic peptide (GIP) suppresses androgen biosynthesis in PCOS mouse models and cellular systems.
    Gynecol Endocrinol. 2025;41:2582506.
    PubMed     Abstract available
    
    
    
21. THOMAS SA, Kempegowda P, Armeni E
    Menopause as a critical window for cardiovascular-kidney-metabolic syndrome prevention: a call for integrated women's health approaches.
    Gynecol Endocrinol. 2025;41:2589608.
    PubMed    
    
    
    
22. LUO H, Lao T, Yang J, Gao X, et al
    Association between dietary antioxidant intakes and female infertility: evidence from the national health and nutrition examination survey 2013-2020.
    Gynecol Endocrinol. 2025;41:2590871.
    PubMed     Abstract available
    
    
    
23. BATTIPAGLIA C, Vescovi V, Foschi M, Righi B, et al
    Combined myo-inositol and Banaba (1% Corosolic Acid) improve HOMA-IR and hepatic insulin extraction index in overweight and obese postmenopausal women.
    Gynecol Endocrinol. 2025;41:2596417.
    PubMed     Abstract available
    
    
    
24. EREL CT, Ozcivit Erkan IB
    Oral versus vaginal micronized progesterone in menopausal hormone therapy.
    Gynecol Endocrinol. 2025;41:2592400.
    PubMed    
    
    
    
25. ZHANG F, Wu J, Ge L, Huang Y, et al
    A review of immunometabolic crosstalk in PCOS-related pregnancy loss: mechanisms and emerging therapeutic strategies.
    Gynecol Endocrinol. 2025;41:2600160.
    PubMed     Abstract available
    
    
    
26. GU M, Ruan X, Li Y, Jia C, et al
    Effect of oral contraceptive pretreatment on IVF outcomes in women with polycystic ovary syndrome using a long GnRH agonist protocol.
    Gynecol Endocrinol. 2025;41:2594876.
    PubMed     Abstract available
    
    
    
27. GU M, Ruan X, Cheng J, Li Y, et al
    Hypoxia-preconditioned hUCMSCs protect frozen-thawed human ovarian tissue by modulating the HIF-1alpha/VEGF pathway.
    Gynecol Endocrinol. 2025;41:2597612.
    PubMed     Abstract available
    
    
    
28. BOZDAG G, Boynukalin FK, Demir B, Gultomruk M, et al
    The assessment of demographic features, follicular phase parameters, and luteal support in mild stimulation frozen embryo transfer cycles for optimal ongoing pregnancy outcome.
    Gynecol Endocrinol. 2025;42:2604865.
    PubMed     Abstract available
    
    
    
29. REGIDOR PA, Colli E
    Comment on Evaluation of the safety profile of prolonged-release EE/DNG oral contraceptives: a critical appraisal.
    Gynecol Endocrinol. 2025;42:2604354.
    PubMed    
    
    
    
30. 
    Statement of Retraction: The adjuvant effect of metformin and N-acetylcysteine to clomiphene citrate in induction of ovulation in patients with Polycystic Ovary Syndrome.
    Gynecol Endocrinol. 2025;41:2600208.
    PubMed    
    
    
    
31. VALENTI VE, Chagas ADS, Chedraui P, de Souza IS, et al
    Effect of combined aerobic exercise and resistance training on postmenopausal women with type 2 diabetes: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2025;41:2450338.
    PubMed     Abstract available
    
    
    
32. LIU Y, Bai H, Guan H, Wang C, et al
    Animal experiments and network pharmacology to explore the anti-inflammatory mechanism of dapagliflozin in the treatment of polycystic ovary syndrome.
    Gynecol Endocrinol. 2025;41:2454432.
    PubMed     Abstract available
    
    
    
33. KUNICKI M, Rzewuska N, Soponska P, Pawlosek A, et al
    Novel serum biomarkers for early diagnosis of gestational diabetes mellitus-a review.
    Gynecol Endocrinol. 2025;41:2455472.
    PubMed     Abstract available
    
    
    
34. JIANG X, Wang Y, Tang H, Ma J, et al
    Effect of light fasting diet therapy on lipid metabolism and sex hormone levels in patients with polycystic ovary syndrome combined with infertility.
    Gynecol Endocrinol. 2025;41:2458084.
    PubMed     Abstract available
    
    
    
35. GENAZZANI AD, Battipaglia C, Foschi M, Semprini E, et al
    Improved insulin sensitivity and reproductive profile in overweight/obese PCOS patients undergoing integrative treatment with carnitines, L-arginine, L-cysteine and myo-inositol.
    Gynecol Endocrinol. 2025;41:2458710.
    PubMed     Abstract available
    
    
    
36. JIAO G, Xing J, Du Z, Bao H, et al
    Biallelic mutations in CDC20 cause female infertility due to oocyte maturation abnormality.
    Gynecol Endocrinol. 2025;41:2451672.
    PubMed     Abstract available
    
    
    
37. SPRITZER PM, Gonzalo Salazar Santos G, Munevar Vega ML, Chedraui P, et al
    Evaluation of the evidence-based practices for the management of PCOS in the Latin America context: the consensus of the Latin American Association of Gynecological Endocrinology (ALEG).
    Gynecol Endocrinol. 2025;41:2456578.
    PubMed     Abstract available
    
    
    
38. ZHANG Y, Chen Y, Liu FY, Fu JW, et al
    A rare deleterious missense mutation in the AXIN2 gene in Chinese women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2025;41:2463545.
    PubMed     Abstract available
    
    
    
39. CUCINELLA L, Barbagallo F, Erroi M, Procaccianti C, et al
    Signs and symptoms of vulvovaginal atrophy (VVA) in clinical practice - the possible involvement of thyroid autoimmunity in genitourinary syndrome of menopause (GSM).
    Gynecol Endocrinol. 2025;41:2458705.
    PubMed     Abstract available
    
    
    
40. CHENG R, Zhu Y, Yang LQ, Xiao L, et al
    Dysregulated serum levels of kisspeptin, NKB, GABA in women with polycystic ovary syndrome and their association with hormonal profiles.
    Gynecol Endocrinol. 2025;41:2463533.
    PubMed     Abstract available
    
    
    
41. ZHU C, Zhang Y, Pan Y, Zhang Z, et al
    Clinical correlation between intestinal flora profiles and the incidence of postmenopausal osteoporosis.
    Gynecol Endocrinol. 2025;41:2465587.
    PubMed     Abstract available
    
    
    
42. REGIDOR PA, Angulo A, Colli E
    Effect over coagulation and fibrinolysis parameters of a prolonged release 24 + 4 daily use regime contraceptive formulation containing 2 mg dienogest/0.02 mg ethinylestradiol.
    Gynecol Endocrinol. 2025;41:2458708.
    PubMed     Abstract available
    
    
    
43. ZHANG X, Ji D, Zhang Y, Du C, et al
    Study on the mechanism of action of berberine combined with Jianpi Yishen Huazhuo formulation in treating obese polycystic ovary syndrome by activating PI3K/AKT signaling pathway.
    Gynecol Endocrinol. 2025;41:2462068.
    PubMed     Abstract available
    
    
    
44. ANAGNOSTIS P, Bosdou JK, Georgiou T, Goulis DG, et al
    Can menopausal hormone therapy be considered in postmenopausal women who are older than 60 years?
    Gynecol Endocrinol. 2025;41:2468957.
    PubMed    
    
    
    
45. CHENG C, Liu S, Yu Z, Zhu K, et al
    Frontiers of premature ovarian insufficiency research: an analysis from the top 100 most influential articles in the field.
    Gynecol Endocrinol. 2025;41:2470986.
    PubMed     Abstract available
    
    
    
46. GUO H, Pan SH, Zhao J, Kong DX, et al
    Reduced DNMT1 expression associated with TP53 promoter hypomethylation mediate enhanced granulosa cell senescence during ovarian aging.
    Gynecol Endocrinol. 2025;41:2471549.
    PubMed     Abstract available
    
    
    
47. ZHAO M, Su X, Huang L
    Early gestational diabetes mellitus risk predictor using neural network with NearMiss.
    Gynecol Endocrinol. 2025;41:2470317.
    PubMed     Abstract available
    
    
    
48. CAGNACCI A, Gambacciani M, Lello S, Paoletti AM, et al
    Indications for the use of menopausal hormone therapy after cancer: on what data should we rely on?
    Gynecol Endocrinol. 2025;41:2477504.
    PubMed    
    
    
    
49. PETRAGLIA F, Angioni S, Di Spiezio Sardo A, Vignali M, et al
    Awareness, burden and treatment of uterine fibroids: a web-based Italian survey.
    Gynecol Endocrinol. 2025;41:2477499.
    PubMed     Abstract available
    
    
    
50. YANG X, Lin T, Luo L, Chen H, et al
    Causal associations between premature ovarian insufficiency and cardiovascular diseases: a Mendelian randomization study.
    Gynecol Endocrinol. 2025;41:2487498.
    PubMed     Abstract available
    
    
    
51. LI J, Zhang Q, Wang X, Fu X, et al
    Association between inflammatory biomarkers and gestational diabetes mellitus in women aged 20-44: a cross-sectional analysis of NHANES 2007-2018.
    Gynecol Endocrinol. 2025;41:2487492.
    PubMed     Abstract available
    
    
    
52. TANG R, Fan Y, Ruan X, Zhang Z, et al
    Changes in menopause-specific quality of life between women with transdermal estradiol versus oral estrogens: results of a randomized controlled trial.
    Gynecol Endocrinol. 2025;41:2484213.
    PubMed     Abstract available
    
    
    
53. HAGER M, Patsch A, Thieme SL, Robin G, et al
    GnRH ability to release FSH and LH in women with functional hypothalamic amenorrhea: a retrospective cohort study about women with and without polycystic ovarian morphology.
    Gynecol Endocrinol. 2025;41:2495604.
    PubMed     Abstract available
    
    
    
54. CHEN X, Xiao Z, Cai Y, Pan Y, et al
    Reproductive hormone characteristics of obese Chinese patients with polycystic ovarian syndrome: a meta-analysis.
    Gynecol Endocrinol. 2025;41:2497854.
    PubMed     Abstract available
    
    
    
55. VAN BREE BE, van der Heijden DMB, van Golde RJT, Brouwers MCGJ, et al
    Sex hormone-binding globulin as a biomarker for metabolic risk in European women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2025;41:2500462.
    PubMed     Abstract available
    
    
    
56. SANCHEZ-PRIETO M, Mendoza N, Chedraui P, Lugo-Salcedo F, et al
    An open, single center, clinical investigation to evaluate the efficacy and safety of a non-hormonal vaginal moisturizer for the symptomatic treatment of vulvovaginal atrophy in postmenopausal woman.
    Gynecol Endocrinol. 2025;41:2500480.
    PubMed     Abstract available
    
    
    
57. YANG X, Xue X, Zhu Y, Zhang Z, et al
    Correlation between lipid metabolism and endometriosis: a meta-analysis.
    Gynecol Endocrinol. 2025;41:2500459.
    PubMed     Abstract available
    
    
    
58. VANNUCCINI S, La Torre F, Toscano F, Speciale AR, et al
    Medical treatment for adenomyosis: long term use of progestins.
    Gynecol Endocrinol. 2025;41:2511329.
    PubMed     Abstract available
    
    
    
59. IBANOGLU MC, Yildiz AG, Tatar OB, Seckin B, et al
    A different approach to PCOS: evaluation of spermiogram results in male patients with a family history of PCOS.
    Gynecol Endocrinol. 2025;41:2501694.
    PubMed     Abstract available
    
    
    
60. SUN Y, Wang J, Chen G
    Effect of letrozole doses on clinical pregnancy rates in polycystic ovary syndrome: a systematic review and network meta-analysis.
    Gynecol Endocrinol. 2025;41:2504977.
    PubMed     Abstract available
    
    
    
61. LI X, Peng X
    The impact of combined use of probiotics and metformin on metabolic parameters in patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2025;41:2504980.
    PubMed     Abstract available
    
    
    
62. LV SJ, Yuan Q, Zong SS, Ye L, et al
    Dissecting the causal effects of interleukin receptor-related factors and the risk of developing endometriosis: a two-sample Mendelian randomization study.
    Gynecol Endocrinol. 2025;41:2512837.
    PubMed     Abstract available
    
    
    
63. WANG FX, Luo Z, Huang YZ, Zhang Y, et al
    Factors associated with menopausal symptoms in southeast Chinese females aged 40-69 years.
    Gynecol Endocrinol. 2025;41:2512832.
    PubMed     Abstract available
    
    
    
64. TARUMI Y, Takaoka O, Izumi Y, Katayama A, et al
    Daidzein-rich isoflavone aglycones inhibit 17beta-hydroxysteroid dehydrogenase 1 and increase estrogen sulfotransferase in endometriosis.
    Gynecol Endocrinol. 2025;41:2516202.
    PubMed     Abstract available
    
    
    
65. ZHANG Y, He F, Cai N, Chen G, et al
    SIRT5 regulates granulosa cell proliferation and apoptosis in polycystic ovarian syndrome via desuccinylation of GLI1.
    Gynecol Endocrinol. 2025;41:2515516.
    PubMed     Abstract available
    
    
    
66. ZHANG B, Zhang Y, Wang T, Gao X, et al
    Association between serum Klotho and all-cause mortality in postmenopausal women: a prospective population-based cohort analysis from NHANES 2007-2016.
    Gynecol Endocrinol. 2025;41:2512831.
    PubMed     Abstract available
    
    
    
67. MEDENICA S, Arjunan D, Mladenovic V, Zankovic N, et al
    Thyroid nodules and thyroid cancer in pregnancy.
    Gynecol Endocrinol. 2025;41:2517878.
    PubMed     Abstract available
    
    
    
68. PENG L, Wang Q, Chen Y, Sun X, et al
    Adding human chorionic gonadotropin to frozen-thawed embryo transfer cycles pretreated with GnRH-a improves clinical pregnancy rates: a retrospective study.
    Gynecol Endocrinol. 2025;41:2513640.
    PubMed     Abstract available
    
    
    
69. SU H, Yang J, Pei L, Su D, et al
    Gonadal function in pediatric female post-Allo-HSCT: a real-life prospective study from China.
    Gynecol Endocrinol. 2025;41:2523420.
    PubMed     Abstract available
    
    
    
70. VIBERT J, Ben Jazia I, Alec M, Benagiano G, et al
    Beyond pain: employment status affects endometriosis-associated quality of life - a cross-sectional study.
    Gynecol Endocrinol. 2025;41:2524496.
    PubMed     Abstract available
    
    
    
71. SEOUD M, Jaafar I, Kojok D, Sleiman S, et al
    Prevalence and predictive factors for vitamin D deficiency in pregnant Lebanese women: a retrospective cohort study.
    Gynecol Endocrinol. 2025;41:2521531.
    PubMed     Abstract available
    
    
    
72. SOARES JUNIOR JM, Ejzenberg D, Chedraui P, Baracat EC, et al
    Uterus transplantation and the complex motivations behind absolute uterine factor infertility.
    Gynecol Endocrinol. 2025;41:2523418.
    PubMed    
    
    
    
73. LIPING W, Chenyue T, Shuai C, Liu G, et al
    circRNA_BMPR2 affects the progression of polycystic ovary syndrome by regulating the expression of Rab43.
    Gynecol Endocrinol. 2025;41:2526559.
    PubMed     Abstract available
    
    
    
74. LI JJ, Wu HL, Lv Y, Qin YM, et al
    Metformin prevents oxidative stress and apoptosis of ovarian granulosa cells in polycystic ovary syndrome via activation of Nrf2-HO-1 pathway.
    Gynecol Endocrinol. 2025;41:2528815.
    PubMed     Abstract available
    
    
    
75. JIA HY, He PY, Zhang J, Zhou MJ, et al
    Association between triglyceride-to-HDL-cholesterol ratio and risk of gestational diabetes mellitus in the first trimester: a retrospective cohort study.
    Gynecol Endocrinol. 2025;41:2528817.
    PubMed     Abstract available
    
    
    
76. CAO Q, Liu D, Zhu H, Wang Q, et al
    Endocrine traits during pregnancy in women with polycystic ovary syndrome - insights from a prospective cohort study in China.
    Gynecol Endocrinol. 2025;41:2530566.
    PubMed     Abstract available
    
    
    
77. GRAZIANO CUSTODIO M, Arab H, da Silva van der Laan A, Pedachenko N, et al
    Unmet needs in the management of abnormal uterine bleeding: insights from social media listening.
    Gynecol Endocrinol. 2025;41:2532613.
    PubMed     Abstract available
    
    
    
78. DU C, Wang N, Ma X, Feng Y, et al
    Evaluating ovarian function in infertile patients: the combined diagnostic utility of anti-mullerian hormone and angiopoietin-like protein 8.
    Gynecol Endocrinol. 2025;41:2530568.
    PubMed     Abstract available
    
    
    
79. GUO Q, Zhou Y, Li L, Chen X, et al
    The protective role of BMP-15 in infertility development with NLRP3 and IL-18 in infertility development in obese patients with PCOS: clinical and mouse model investigations.
    Gynecol Endocrinol. 2025;41:2530571.
    PubMed     Abstract available
    
    
    
80. HUANG X, Yu F
    Hsa_circ_0020491 promotes polycystic ovary syndrome by interacting with IGF2BP2 through regulation of granular cell autophagy and mitochondrial dysfunction.
    Gynecol Endocrinol. 2025;41:2536579.
    PubMed     Abstract available
    
    
    
81. SHAO F, Li Y
    Premature ovarian insufficiency as a consequence of immunological abnormalities and dyslipidemia: a Mendelian randomization study.
    Gynecol Endocrinol. 2025;41:2541647.
    PubMed     Abstract available
    
    
    
82. TIAN Y, Li F, Kuang T, Li X, et al
    The oxylipins profile and their associations with embryo quality of women with polycystic ovary syndrome: a prospective cohort study.
    Gynecol Endocrinol. 2025;41:2541658.
    PubMed     Abstract available
    
    
    
83. HE W, Li X, Ma J, Wang X, et al
    Clinical value of elevated miR-142-3p in subclinical hypothyroidism during the second trimester of pregnancy.
    Gynecol Endocrinol. 2025;41:2533482.
    PubMed     Abstract available
    
    
    
84. PALACIOS S
    Hyaluronic acid in the management of postmenopausal vaginal atrophy: from moisturizer to mucosal regenerator.
    Gynecol Endocrinol. 2025;41:2545368.
    PubMed    
    
    
    
85. YOU Y, Li X, Guo Z, Hong X, et al
    Effect of impaired sensitivity to thyroid hormones on the risk of insulin resistance and dyslipidemia in polycystic ovary syndrome patients.
    Gynecol Endocrinol. 2025;41:2537275.
    PubMed     Abstract available
    
    
    
86. GENAZZANI AR, Fidecicchi T, Arduini D, Benagiano G, et al
    Contraception today and family planning: a comprehensive review and position statement on the ethical, medical, and social dimensions of modern contraception.
    Gynecol Endocrinol. 2025;41:2543423.
    PubMed     Abstract available
    
    
    
87. NING B, Zhang M, Su N, Bur R, et al
    Global, regional, and national burden of polycystic ovary syndrome, 1990-2021: a comprehensive analysis of trends and projections based on the global burden of disease 2021 study.
    Gynecol Endocrinol. 2025;41:2535737.
    PubMed     Abstract available
    
    
    
88. DING H, Qin X, Li Y, Fang Y, et al
    Deciphering the role of hsa-piR-775 in primary ovarian insufficiency through FOXG1 modulation.
    Gynecol Endocrinol. 2025;41:2532615.
    PubMed     Abstract available
    
    
    December 2024
89. LI XL, Ji YF, Feng Y, Liu SW, et al
    Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators.
    Gynecol Endocrinol. 2024;40:2312895.
    PubMed     Abstract available
    
    
    
90. WU H, Wu P, Zhu Y, Li J, et al
    Bushen Huoxue Recipe inhibits endometrial epithelial-mesenchymal transition through the transforming growth factor-beta/nuclear factor kappa-B pathway to improve polycystic ovary syndrome-mediated infertility.
    Gynecol Endocrinol. 2024;40:2325000.
    PubMed     Abstract available
    
    
    
91. 
    Statement of Retraction: Evaluation of prolonged use of statins on the clinical and biochemical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2024;40:2316451.
    PubMed    
    
    
    
92. 
    Expression of Concern: Laparoscopic ovarian drilling versus GnRH antagonist combined with cabergoline as a prophylaxis against the re-development of ovarian hyperstimulation syndrome.
    Gynecol Endocrinol. 2024;40:2307189.
    PubMed    
    
    
    
93. 
    Expression of Concern: Evaluation of the correlation between insulin like factor 3, polycystic ovary syndrome, and ovarian maldescent.
    Gynecol Endocrinol. 2024;40:2307182.
    PubMed    
    
    
    
94. HUANG S, Huang X, Wen X, Liu X, et al
    Enhanced glycolysis in the myometrium with ectopic endometrium of patients with adenomyosis: a preliminary study.
    Gynecol Endocrinol. 2024;40:2332411.
    PubMed     Abstract available
    
    
    
95. LA TORRE F, Vannuccini S, Toscano F, Gallucci E, et al
    Long-term treatment for endometriosis with dienogest: efficacy, side effects and tolerability.
    Gynecol Endocrinol. 2024;40:2336121.
    PubMed     Abstract available
    
    
    
96. CHATZIVASILEIOU P, Armeni E, Chedraui P, Kontou L, et al
    Postmenopausal women with higher TSH values within the normal range present improved handgrip strength: a pilot study.
    Gynecol Endocrinol. 2024;40:2333432.
    PubMed     Abstract available
    
    
    
97. SALAZAR-POUSADA D, Ortega-Uscocovich V, Ramirez-Moran C, Chedraui P, et al
    Menopausal symptoms and the awareness of menopausal-related information in low-income mid-aged women from Guayaquil, Ecuador.
    Gynecol Endocrinol. 2024;40:2333418.
    PubMed     Abstract available
    
    
    
98. MONTERROSA-CASTRO A, Monterrosa-Blanco A, Sanchez-Zarza S
    Possible association between subclinical hypothyroidism and age at menopause in Colombian women.
    Gynecol Endocrinol. 2024;40:2334798.
    PubMed     Abstract available
    
    
    
99. 
    Statement of Retraction: The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2024;40:2334596.
    PubMed    
    
    
    
100. GENAZZANI AD, Battipaglia C, Rusce L, Prampolini G, et al
     Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients.
     Gynecol Endocrinol. 2024;40:2341701.
     PubMed     Abstract available
     
     
     
101. LIU H, Mo L, Tian X, Fan S, et al
     Correlation between anti-mullerian hormone in polycystic ovarian syndrome with metformin: a systematic review and meta-analysis.
     Gynecol Endocrinol. 2024;40:2330655.
     PubMed     Abstract available
     
     
     
102. 
     Statement of Retraction: Long-term effects of combined simvastatin and metformin treatment on the clinical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome.
     Gynecol Endocrinol. 2024;40:2316453.
     PubMed    
     
     
     
103. RUAN Z, Yu Z, Qin Q, Tang Y, et al
     Diagnostic value of ultrasound elastography in polycystic ovary syndrome: a systematic review and meta-analysis.
     Gynecol Endocrinol. 2024;40:2352139.
     PubMed     Abstract available
     
     
     
104. TING Z, Xinghua T, Xiao X, Lingchuan L, et al
     The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome.
     Gynecol Endocrinol. 2024;40:2352136.
     PubMed     Abstract available
     
     
     
105. WEI C, Wu H, Yu Y, Li Y, et al
     Effect of estrogen exposure on pregnancy outcomes in artificial frozen-thawed embryo transfer cycles.
     Gynecol Endocrinol. 2024;40:2352142.
     PubMed     Abstract available
     
     
     
106. CHEN L, Kong C
     SIRT2-dependent DKK1 deacetylation aggravates polycystic ovary syndrome by targeting the TGF-beta1/Smad3 signaling pathway.
     Gynecol Endocrinol. 2024;40:2353733.
     PubMed     Abstract available
     
     
     
107. ZUCHELO LTS, Alves MS, Baracat EC, Sorpreso ICE, et al
     Menstrual pattern in polycystic ovary syndrome and hypothalamic-pituitary-ovarian axis immaturity in adolescents: a systematic review and meta-analysis.
     Gynecol Endocrinol. 2024;40:2360077.
     PubMed     Abstract available
     
     
     
108. XU YP, Fu JC, Hong ZL, Zeng DF, et al
     Psychological stressors involved in the pathogenesis of premature ovarian insufficiency and potential intervention measures.
     Gynecol Endocrinol. 2024;40:2360085.
     PubMed     Abstract available
     
     
     
109. FERNANDEZ-ALONSO AM, Chedraui P, Perez-Lopez FR
     Nonalcoholic fatty liver disease risk in polycystic ovary syndrome patients.
     Gynecol Endocrinol. 2024;40:2359031.
     PubMed    
     
     
     
110. SHI D, Du J, Kang H, Feng L, et al
     The effect of subclinical hypothyroidism on hormonal and metabolic profiles and ovarian morphology in patients with polycystic ovary syndrome: a cross-sectional study.
     Gynecol Endocrinol. 2024;40:2358219.
     PubMed     Abstract available
     
     
     
111. LI L, Kou Z, Zhao F, Wang Y, et al
     Network meta-analysis of four common immunomodulatory therapies for the treatment of patients with thin endometrium.
     Gynecol Endocrinol. 2024;40:2360072.
     PubMed     Abstract available
     
     
     
112. STUTE P, Henneicke-von Zepelin HH, Nicken P
     Transfer of preclinical study data on the influence of cimicifuga racemosaon functional changes in the hippocampus during menopause.
     Gynecol Endocrinol. 2024;40:2360066.
     PubMed     Abstract available
     
     
     
113. 
     Statement of Retraction: Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial.
     Gynecol Endocrinol. 2024;40:2349424.
     PubMed    
     
     
     
114. CEVIK DOGAN M, Yoldemir T
     The association between female sexual function and metabolic features of the polycystic ovary syndrome in Turkish women of reproductive age.
     Gynecol Endocrinol. 2024;40:2362249.
     PubMed     Abstract available
     
     
     
115. LONGO M, Greco E, Listorti I, Varricchio MT, et al
     Telomerase activity, telomere length, and the euploidy rate of human embryos.
     Gynecol Endocrinol. 2024;40:2373742.
     PubMed     Abstract available
     
     
     
116. SIMONCINI T, Arab H, Pedachenko N, Tian Q, et al
     Unmet needs in abnormal uterine bleeding due to ovulatory dysfunction.
     Gynecol Endocrinol. 2024;40:2362244.
     PubMed     Abstract available
     
     
     
117. NASATZKY M, Belicha Y, Fainaru O
     Clinical parameters that predict a premature LH rise in patients undergoing ovarian stimulation for IVF.
     Gynecol Endocrinol. 2024;40:2365913.
     PubMed     Abstract available
     
     
     
118. SHEN D, Wang Y, Hu P, Qi C, et al
     Analyzing the infertility burden of polycystic ovarian syndrome in China: A comprehensive age-period-cohort analysis with future burden prediction (1990-2030).
     Gynecol Endocrinol. 2024;40:2362251.
     PubMed     Abstract available
     
     
     
119. NONG J, Li H, Yang Y, Lu Q, et al
     Low serum hepcidin levels in women with polycystic ovary syndrome: evidence from meta-analysis.
     Gynecol Endocrinol. 2024;40:2375568.
     PubMed     Abstract available
     
     
     
120. TATARCHUK T, Stevenson JC, Yu Q, Kahler E, et al
     Ultra-low-dose continuous combined estradiol and dydrogesterone in postmenopausal women: A pooled safety and tolerability analysis.
     Gynecol Endocrinol. 2024;40:2375577.
     PubMed     Abstract available
     
     
     
121. ZHANG Y, Feng H, Li X, Chen Q, et al
     Association of dietary glycemic index and glycemic load with the risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis.
     Gynecol Endocrinol. 2024;40:2375564.
     PubMed     Abstract available
     
     
     
122. 
     Statement of Retraction: Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
     Gynecol Endocrinol. 2024;40:2373613.
     PubMed    
     
     
     
123. YIFU P
     A review of antioxidant N-acetylcysteine in addressing polycystic ovary syndrome.
     Gynecol Endocrinol. 2024;40:2381498.
     PubMed     Abstract available
     
     
     
124. ZHAO X, Yu Z, Wang X, Li X, et al
     The administration of human amniotic epithelial cells in premature ovarian insufficiency: From preclinical to clinical.
     Gynecol Endocrinol. 2024;40:2382818.
     PubMed     Abstract available
     
     
     
125. ZENG H, Wang Y
     Effects of various controlled ovarian hyperstimulation protocols and surgery on pregnancy outcomes in women with endometriosis.
     Gynecol Endocrinol. 2024;40:2381504.
     PubMed     Abstract available
     
     
     
126. ZHENG X, Zhou C, Xu W, Jia J, et al
     Protective effect of Yunkang oral liquid via regulating androgen receptor in polycystic ovary syndrome rats.
     Gynecol Endocrinol. 2024;40:2368845.
     PubMed     Abstract available
     
     
     
127. 
     Statement of Retraction: Luteal support with vaginal dydrogesterone increases pregnancy rate in patients with clomifene resistant polycystic ovary syndrome receiving letrozole for ovulation induction.
     Gynecol Endocrinol. 2024;40:2381309.
     PubMed    
     
     
     
128. REGIDOR PA, Colli E, Jakimiuk A
     The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users' acceptability and newborn development.
     Gynecol Endocrinol. 2024;40:2382800.
     PubMed     Abstract available
     
     
     
129. WANG H, Sui L, Xu Q, Li M, et al
     Common obesity-related anthropometric indices and the risk of gestational diabetes mellitus in a Chinese population: a prospective cohort study.
     Gynecol Endocrinol. 2024;40:2390848.
     PubMed     Abstract available
     
     
     
130. JIANG M, Sui R, Wu X
     Association between sleep quality and duration during pregnancy and risk of gestational diabetes: A systematic review and meta-analysis.
     Gynecol Endocrinol. 2024;40:2391925.
     PubMed     Abstract available
     
     
     
131. BERGER AS, Sourouni M, Bitterlich N, Blickenstorfer K, et al
     Time-efficient consultation hours in the department of gynecological endocrinology.
     Gynecol Endocrinol. 2024;40:2396628.
     PubMed     Abstract available
     
     
     
132. KONG M, Xu X, Xiang L, Wang C, et al
     Case report: Ovarian steroid cell tumor with CA72-4 elevated.
     Gynecol Endocrinol. 2024;40:2400943.
     PubMed     Abstract available
     
     
     
133. LIU X, Wang F, Wang X, Luan Q, et al
     Impact of body mass index and polycystic ovary syndrome (PCOS) subtypes on periodontal health in Chinese women with PCOS and periodontitis.
     Gynecol Endocrinol. 2024;40:2405097.
     PubMed     Abstract available
     
     
     
134. ASHKAR A, Jadoon B, Ali Baig MM, Irfan SA, et al
     Is combined letrozole and clomiphene superior to either as monotherapy: a systemic review and meta-analysis based on clinical trials.
     Gynecol Endocrinol. 2024;40:2405114.
     PubMed     Abstract available
     
     
     
135. JIN YX, Hu HQ, Zhang JC, Xin XY, et al
     Research status of polycystic ovary syndrome treatment: a mini review and a bibliometric analysis from 2010 to 2023.
     Gynecol Endocrinol. 2024;40:2405098.
     PubMed     Abstract available
     
     
     
136. WANG J, Chen Q, Zhang S
     Influence of vitamin D-calcium on metabolic profile for gestational diabetes: a meta-analysis of randomized controlled trials.
     Gynecol Endocrinol. 2024;40:2409139.
     PubMed     Abstract available
     
     
     
137. 
     Statement of Retraction: Can Metformin reduce the incidence of Gestational Diabetes Mellitus in pregnant women with polycystic ovary syndrome? Prospective Cohort Study.
     Gynecol Endocrinol. 2024;40:2401196.
     PubMed    
     
     
     
138. MAZZERA I, Graziano A, Vizzielli G, Driul L, et al
     The role of inositols during pregnancies complicated by gestational diabetes mellitus: a narrative review.
     Gynecol Endocrinol. 2024;40:2411727.
     PubMed     Abstract available
     
     
     
139. CHEN Y, Li Y, Li X, Liu L, et al
     Lower serum LH level was related to poor embryo quality and adverse pregnancy outcomes in fixed GnRH antagonist protocol with estradiol pretreatment.
     Gynecol Endocrinol. 2024;40:2409147.
     PubMed     Abstract available
     
     
     
140. LIN Y, Sun H, Ming Y, Wang X, et al
     Efficacy and uterine bleeding patterns in initiating goserelin therapy during different menstrual phases in patients with adenomyosis: a prospective cohort study.
     Gynecol Endocrinol. 2024;40:2409918.
     PubMed     Abstract available
     
     
     
141. ZHANG N, Zhou H
     Optimizing timing for intrauterine insemination (IUI) in donor sperm cycles: pre- versus post-ovulation insemination in natural cycles.
     Gynecol Endocrinol. 2024;40:2413164.
     PubMed     Abstract available
     
     
     
142. LOKSHIN VN, Temirkhanovna Abshekenova A, Di Renzo GC, Feichtinger M, et al
     Cytoplasmic sperm injection (ICSI) - A systematic review of the literature.
     Gynecol Endocrinol. 2024;40:2414783.
     PubMed     Abstract available
     
     
     
143. YANG X, Jiang L, Xu Y
     HSD11B1 overexpression in dendritic cells and stromal cells relates to endometriosis by inhibiting dendritic cell proliferation and maturation.
     Gynecol Endocrinol. 2024;40:2411607.
     PubMed     Abstract available
     
     
     
144. LIHUA C, Hua S, Wenzhan W, Standard J, et al
     Expression and clinical significance of lncRNA PART1 in patients with unexplained recurrent pregnancy loss.
     Gynecol Endocrinol. 2024;40:2375582.
     PubMed     Abstract available
     
     
     
145. GIANNINI A, Massimello F, Caretto M, Cosimi G, et al
     Factors in malignant transformation of ovarian endometriosis: A narrative review.
     Gynecol Endocrinol. 2024;40:2409911.
     PubMed     Abstract available
     
     
     
146. ZERROUKI D, Rami I, Assarrar I, Bouichrat N, et al
     Is there any association between vitamin D status and PCOS disease?
     Gynecol Endocrinol. 2024;40:2381501.
     PubMed     Abstract available
     
     
     
147. GUO Q, Wang W, Chen J, Ma WR, et al
     Association of SOGPI in mediating the effect of Phosphatidylcholine on polycystic Ovary Syndrome.
     Gynecol Endocrinol. 2024;40:2420963.
     PubMed     Abstract available
     
     
     
148. ALVAREZ-CORDOVA LR, Artacho R, Chedraui P, Arteaga-Pazmino C, et al
     Arm muscle area is correlated to handgrip strength in postmenopausal women.
     Gynecol Endocrinol. 2024;40:2420937.
     PubMed     Abstract available
     
     
     
149. TAN J, Fan L, Li X, Xia LZ, et al
     GnRH antagonist impairs the process of embryo implantation by inhibiting motility of endometrial stromal cells through reducing c-kit expression.
     Gynecol Endocrinol. 2024;40:2421487.
     PubMed     Abstract available
     
     
     
150. LI Y, Ye Y, Zhang H, Yang Y, et al
     MiR-19b-3p inhibits cell viability and proliferation and promotes apoptosis by targeting IGF1 in KGN cells.
     Gynecol Endocrinol. 2024;40:2425318.
     PubMed     Abstract available
     
     
     
151. KO YR, Kim TH, Jin Hee E, Lee WS, et al
     Associations between maternal MTHFR polymorphisms and embryological outcomes in Korean patients with infertility undergoing IVF/ICSI cycles.
     Gynecol Endocrinol. 2024;40:2431224.
     PubMed     Abstract available
     
     
     
152. 
     Statement of retraction: Impact of unilateral versus bilateral laparoscopic ovarian drilling on ovarian reserve and pregnancy rate: a randomized clinical trial.
     Gynecol Endocrinol. 2024;40:2429931.
     PubMed    
     
     
     
153. RUSSO E, Brancalion MF, Fidecicchi T, Montt-Guevara MM, et al
     Design and methodology of the 'endometriosis and pelvic floor dysfunction' (EndoPFD) multicenter cross-sectional study.
     Gynecol Endocrinol. 2024;40:2432479.
     PubMed     Abstract available
     
     
     
154. WANG Z, Ruan X, Du J, Jin F, et al
     Ovarian tissue cryopreservation for an 8 year old girl after hematopoietic stem cell transplantation in China: case report and literature review.
     Gynecol Endocrinol. 2024;40:2431219.
     PubMed     Abstract available
     
     
     
155. WANG J, Wang Y, Li S, Fang X, et al
     Exploring acetylation-related gene markers in polycystic ovary syndrome: insights into pathogenesis and diagnostic potential using machine learning.
     Gynecol Endocrinol. 2024;40:2427202.
     PubMed     Abstract available
     
     
     
156. HUANG X, Gong B, Cai Y, Wang W, et al
     Evaluation of Femoston and Dydrogesterone therapy for incomplete abortion: a retrospective cohort study.
     Gynecol Endocrinol. 2024;40:2434126.
     PubMed     Abstract available
     
     
     
157. 
     Expression of Concern: Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
     Gynecol Endocrinol. 2024;40:2429857.
     PubMed    
     
     
     
158. LIANG Y, Yang R, Wei Y, Huang B, et al
     Multicenter, prospective, single-arm clinical study to investigate the efficacy and safety of Zoladex (Goserelin acetate) 10.8 mg prior to surgery in Chinese premenopausal women with symptomatic uterine fibroids.
     Gynecol Endocrinol. 2024;40:2427190.
     PubMed     Abstract available
     
     
     
159. FENG W, Xie X, Su Y, Jin R, et al
     Relationship of adiponectin, leptin and reproductive endocrine hormones with insulin resistance in polycystic ovary syndrome patients with normal BMI.
     Gynecol Endocrinol. 2024;40:2439886.
     PubMed     Abstract available
     
     
     
160. D GUNGOR N, Celik O, Ulug U, Celik N, et al
     Hyperandrogenemia impairs endometrial vitamin D receptor expression in polycystic ovary syndrome.
     Gynecol Endocrinol. 2024;40:2435469.
     PubMed     Abstract available
     
     
     
161. WANG X, Yang CR, Zhao ZD, Liu DG, et al
     Gelatin/polycaprolactone membranes promote endometrial regeneration and restore fertility.
     Gynecol Endocrinol. 2024;40:2442728.
     PubMed     Abstract available
     
     
     
162. YOLDEMIR T
     Postmenopausal endometriosis.
     Gynecol Endocrinol. 2024;40:2441299.
     PubMed    
     
     
     
163. RUAN X
     Standardization for ovarian tissue cryopreservation and transplantation in China.
     Gynecol Endocrinol. 2024;40:2431223.
     PubMed     Abstract available
     
     
     
164. WU L, Chen F, Chen M, Hu Y, et al
     Additive interaction of pre-pregnancy BMI and assisted reproductive technology on the risk of pregnancy-induced hypertension.
     Gynecol Endocrinol. 2024;40:2433136.
     PubMed     Abstract available
     
     
     
165. GONG Z, Zhang L, Shi Y
     The potential role of uric acid in women with polycystic ovary syndrome.
     Gynecol Endocrinol. 2024;40:2323725.
     PubMed     Abstract available
     
     
     
166. WAN X, Lai X, Huang M, Yu M, et al
     The role of mitochondrial DNA copy number in female infertility: a bidirectional two-sample Mendelian randomization study.
     Gynecol Endocrinol. 2024;40:2444380.
     PubMed     Abstract available
     
     
     
167. JIANG L, Ruan X, Du J, Cheng J, et al
     Ovarian tissue cryopreservation for a girl with combined severe hemolytic anemia due to pyruvate kinase deficiency: a case report and literature review.
     Gynecol Endocrinol. 2024;40:2431231.
     PubMed     Abstract available
     
     
     May 2024
168. SHI Z, Zhao W, Wu X, Bi X, et al
     Comparison of the pregnancy outcomes of progestin-primed vs. antagonist ovarian stimulation in patients with poor ovarian response: a retrospective study.
     Gynecol Endocrinol. 2024;40:2352133.
     PubMed     Abstract available
     
     
     
169. LIU K, Lei X, Zhao L, Yu H, et al
     Cognitive shadows in perimenopause: linking subjective cognitive decline (SCD) to menopausal symptom severity.
     Gynecol Endocrinol. 2024;40:2352134.
     PubMed     Abstract available
     
     
     March 2024
170. GARCIA-VIGARA A, Fernandez-Garrido J, Chedraui P, Monllor-Tormos A, et al
     Association between anxiety and frailty in postmenopausal women.
     Gynecol Endocrinol. 2024;40:2329714.
     PubMed     Abstract available
     
     
     
171. WU Y, Liu C, Huang J, Wang F, et al
     Quantitative proteomics reveals pregnancy prognosis signature of polycystic ovary syndrome women based on machine learning.
     Gynecol Endocrinol. 2024;40:2328613.
     PubMed     Abstract available
     
     
     
172. SANCHEZ-PRIETO M, Pingarron C, Bergamaschi L, Bermudez JC, et al
     Prospective, multicenter, uncontrolled study on the effectiveness and safety of a hyaluronic acid water-based vaginal lubricant in alleviating vaginal dryness and dyspareunia.
     Gynecol Endocrinol. 2024;40:2317268.
     PubMed     Abstract available
     
     
     
173. LIU H, Fang X, Ma Q, Wang M, et al
     Research hotspots of polycystic ovary syndrome and hyperandrogenism from 2008 to 2022: bibliometric analysis.
     Gynecol Endocrinol. 2024;40:2326102.
     PubMed     Abstract available
     
     
     February 2024
174. TIAN W, Cao S, Zhang W, Quan C, et al
     Interaction between XRCC2 gene polymorphism and abdominal obesity on risk of endometrial carcinoma.
     Gynecol Endocrinol. 2024;40:2317270.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum